{"classes":[{"categories":[{"measurements":[{"groupId":"OG000","spread":".77","value":".47"},{"groupId":"OG001","spread":".55","value":"-.02"},{"groupId":"OG002","spread":".54","value":"-.34"}]}],"title":"Change at 1-Month"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"1.00","value":".41"},{"groupId":"OG001","spread":".96","value":".36"},{"groupId":"OG002","spread":".60","value":"-.63"}]}],"title":"Change at 3-Month"}],"denoms":[{"counts":[{"groupId":"OG000","value":"7"},{"groupId":"OG001","value":"10"},{"groupId":"OG002","value":"11"}],"units":"Participants"}],"description":"Electrophysiological component that measures allocation of attentional resources","dispersionType":"Standard Deviation","groups":[{"description":"Study patients diagnosed with HM that are scheduled to receive chemotherapy treatment.","id":"OG000","title":"HM - Chemotherapy"},{"description":"Study patients diagnosed with HM that are scheduled to receive non-chemotherapy treatment options.","id":"OG001","title":"HM - No Chemotherapy"},{"description":"Study participants that are demographically matched to HM study patients and meet all inclusion criteria","id":"OG002","title":"Healthy Controls"}],"paramType":"MEAN","populationDescription":"Differences in number analyzed and numbers in the Participant Flow module were due to patient dropout and either: (1) a minority of patients requesting not to complete testing; or (2) difficulties with electrophysiology or stimulus presentation equipment.","reportingStatus":"POSTED","timeFrame":"Collected at Study Induction, 1 month after Study Induction, 3 months after Study Induction","title":"Change From Baseline N2pc Amplitude at 1- and 3- Months","type":"PRIMARY","unitOfMeasure":"microvolts"}